Avalo is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
Avalo is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need. We combine breakthroughs in the understanding of disease pathology and development of novel therapeutics to address underlying disease mechanisms. Our mission is to transform patients’ lives with novel therapeutics that realize the promise of first-in-class medicines.
View PipelineWe share a commitment to teamwork, passion for science, and dedication to patients and families suffering from serious and rare diseases. Our cross-functional team has a deep understanding of disease pathology and clinical development of novel therapeutic targets. Our collective expertise in discovery, development, and regulatory approvals is evidenced in our strong individual track records of advancing multiple therapeutic programs to successful commercialization.
View Leadership Team
